CB
55
2
CMS
64
4
MPC
44
3
FMC
37
-2
FDX
44
-2
TEL
66
-3
VRSN
58
2
FLR
56
-2
GM
65
-7
ED
55
3
KO
47
-2
WU
34
-2
LLY
53
6
STZ
52
-5
UA
57
-8
PGR
68
3
ADBE
61
11
AEP
58
4
PSA
63
2
VRSK
82
2
CB
55
2
CMS
64
4
MPC
44
3
FMC
37
-2
FDX
44
-2
TEL
66
-3
VRSN
58
2
FLR
56
-2
GM
65
-7
ED
55
3
KO
47
-2
WU
34
-2
LLY
53
6
STZ
52
-5
UA
57
-8
PGR
68
3
ADBE
61
11
AEP
58
4
PSA
63
2
VRSK
82
2
Financhill
Back

Assembly Biosciences 10K Form

Sell
35

ASMB
Assembly Biosciences

Last Price:
15.15
Seasonality Move:
15.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ASMB News And Ratings

See the #1 stock for the next 7 days that we like better than ASMB

ASMB Financial Statistics

Sales & Book Value

Annual Sales: $7.16M
Cash Flow: $-15.24M
Price / Cash Flow: 3.79
Annual Sales: $4.09
Price / Book: 3.72

Profitability

EPS (TTM): -6.92000
Net Income (TTM): $-40.8M
Gross Margin: $0
Return on Equity: -115.86%
Return on Assets: -38.94%

Assembly Biosciences Earnings Forecast

Key Assembly Biosciences Financial Ratios

  • The Selling, General & Administrative Expenses for ASMB have been equal to 319.82% of Gross Profit Margin.
  • The Research & Development expenses have been 682.67% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 16 years have been positive in 11 years.

Assembly Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ASMB
CUSIP: 045396
Website: assemblybio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.36
Quick Ratio: 2.28

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ASMB Technical Analysis vs Fundamental Analysis

Sell
35
Assembly Biosciences (ASMB) is a Sell

Is Assembly Biosciences a Buy or a Sell?